Cegedim Stock price

Equities

CGM

FR0000053506

Software

Real-time Euronext Paris 12:35:25 2024-03-28 pm EDT 5-day change 1st Jan Change
13 EUR -15.36% Intraday chart for Cegedim -18.44% -27.21%
Sales 2023 616M 664M Sales 2024 * 652M 703M Capitalization 177M 191M
Net income 2023 -7M -7.54M Net income 2024 * 17M 18.32M EV / Sales 2023 0.4 x
Net Debt 2023 * 199M 214M Net Debt 2024 * 187M 202M EV / Sales 2024 * 0.56 x
P/E ratio 2023
-35.7 x
P/E ratio 2024 *
12.1 x
Employees 6,469
Yield 2023 *
1.92%
Yield 2024 *
4.23%
Free-Float 43.41%
More Fundamentals * Assessed data
Dynamic Chart
1 day-15.36%
1 week-18.44%
Current month-18.75%
1 month-18.75%
3 months-26.88%
6 months-27.05%
Current year-27.21%
More quotes
1 week
11.30
Extreme 11.3
16.22
1 month
11.30
Extreme 11.3
16.68
Current year
11.30
Extreme 11.3
18.80
1 year
11.30
Extreme 11.3
23.55
3 years
11.30
Extreme 11.3
29.80
5 years
11.30
Extreme 11.3
33.20
10 years
11.30
Extreme 11.3
44.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 81 69-08-26
Director of Finance/CFO - 16-06-13
Chief Investment Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 81 69-08-26
Director/Board Member 67 16-06-13
Director/Board Member 70 83-12-31
More insiders
Date Price Change Volume
24-03-28 13 -15.36% 108,590
24-03-27 15.36 +1.45% 1,906
24-03-26 15.14 -3.69% 17,382
24-03-25 15.72 -2.12% 3,476
24-03-22 16.06 +0.75% 322

Real-time Euronext Paris, March 28, 2024 at 12:35 pm EDT

More quotes
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (72.1%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (27.4%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (0.5%). France accounts for 89.5% of net sales.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
13 EUR
Average target price
21.03 EUR
Spread / Average Target
+61.79%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Cegedim - Euronext Paris